Lipids

, Volume 38, Issue 4, pp 317–321 | Cite as

Diets could prevent many diseases

Articles

Abstract

The 2002 ISSFAL Meeting arranged a special evening discussion with professional dietitians about diet-tissue-disease relationships involving essential fatty acids and eicosanoids. The balance of eicosanoid precursors in human tissues differs widely, reflecting voluntary dietary choices among different groups worldwide. An empirical quantitative diet-tissue relationship fits these diverse values as well as other research reports on essential fatty acid metabolism. Information for dietitians and nutritionists about essential fatty acids and eicosanoids is also given in two distance learning web sites, http://ods.od.nih.gov/eicosanoids/ and http:// efaeducation.nih.gov/, which facilitate dietitian education and diet counseling. These sites also have an innovative, interactive diet planning software program with the empirical equation embedded in it to help evaluate personal food choices in the context of the diet-tissue-disease relationship and other widely recommended dietary advice.

Abbreviations

AA

arachidonic acid

CHD

coronary heart disease

DGLA

di-homo-γ-linolenic acid

HUFA

highly unsaturated fatty acids

MRFIT

multiple risk factor intervention trial

NSAID

non-steroidal anti-inflammatory drugs

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Lands, W.E.M. (1979) The Biosynthesis and Metabolism of Prostaglandins, Annu. Rev. Physiol. 41, 633–652.CrossRefPubMedGoogle Scholar
  2. 2.
    Kulmacz, R.J., Pendleton, R.B., and Lands, W.E.M. (1994) Interaction Between Peroxidase and Cyclooxygenase Activities in Prostaglandin-Endoperoxide Synthase, J. Biol. Chem. 269, 5527–5536.PubMedGoogle Scholar
  3. 3.
    Malkowski, M.G., Thuresson, E.D., Lakkides, K.M., Rieke, C.J., Micielli, R., Smith, W.L., and Garavito, R.M. (2001) Structure of Eicosapentaenoic and Linoleic Acids in the Cyclooxygenase Site of Prostaglandin Endoperoxide H Synthase-1, J. Biol. Chem. 276, 37547–37555.CrossRefPubMedGoogle Scholar
  4. 4.
    Needleman, P., Raz, A., Minkes, M.S., Ferrendelli, J.A., and Sprecher, H. (1979) Triene Prostaglandins: Prostacyclin and Thromboxane Biosynthesis and Unique Biological Properties, Proc. Natl. Acad. Sci. USA 76, 944–948.CrossRefPubMedGoogle Scholar
  5. 5.
    Lands, W.E.M., and Samuelsson, B. (1968) Phospholipid Precursors of Prostaglandin, Biochim. Biophys. Acta 164, 426–429.PubMedGoogle Scholar
  6. 6.
    Mohrhauer, H., and Holman, R.T. (1963) Effect of Linolenic Acid upon the Metabolism of Linoleic Acid, J. Nutr. 81, 67–74.PubMedGoogle Scholar
  7. 7.
    Mohrhauer, H., and Holman, R.T. (1963) The Effect of Dose Level of Essential Fatty Acids upon Fatty Acid Composition of the Rat Liver, J. Lipid Res. 4, 151–159.PubMedGoogle Scholar
  8. 8.
    Harris W.S., Ginsberg, H., Arunakul, N., Shachter, N.S., Windsor, S.L., Adams, M., Berglund, L., and Osmundsen, K. (1997) Safety and Efficacy of Omacor in Severe Hypertriglyceridemia, J. Cardiovasc. Risk 4, 385–391.CrossRefPubMedGoogle Scholar
  9. 9.
    Kobayashi, M., Sasaki, S., Kawabata, T., Hasegawa, K., Akabane, M., and Tsugane, S. (2001) Single Measurement of Serum Phospholipid Fatty Acid as a Biomarker of Specific Fatty Acid Intake in Middle-Aged Japanese Men, Eur. J. Clin. Nutr. 55, 643–650.CrossRefPubMedGoogle Scholar
  10. 10.
    Lands, W.E.M., Hamazaki, T., Yamazaki, K., Okuyama, H., Sakai, K., Goto, Y., and Hubbard, V.S. (1990) Changing Dietary Patterns, Am. J. Clin. Nutr. 51, 991–993.PubMedGoogle Scholar
  11. 11.
    Lands, W.E.M. (1991) Biosynthesis of Prostaglandins, Annu. Rev. Nutr. 11, 41–60.CrossRefPubMedGoogle Scholar
  12. 12.
    Lands, W.E.M., Libelt, B., Morris, A., Kramer, N.C., Prewitt, T.E., Bowen, P., Schmeisser, D., Davidson, M.H., and Burns, J.H. (1992) Mamtenance of Lower Proportions of n−6 Eicosanoid Precursors in Phospholipids of Human Plasma in Response to Added Dietary n−3 Fatty Acids, Biochim. Biophys. Acta 1180, 147–162.PubMedGoogle Scholar
  13. 13.
    Dolecek, T.A., and Granditis, G. (1991) Dietary Polyunsaturated Fatty Acids and Mortality in the Multiple Risk Factor Intervention Trial (MRFIT), World Rev. Nutr. Diet. 66, 205–216.PubMedGoogle Scholar
  14. 14.
    Dewailly, E., Blanchet, C., Lemieux, S., Sauve, L., Gingras, S., Ayotte, P., and Holub, B.J. (2002) n−3 Fatty Acids and Cardiovascular Disease Risk Factors Among the Inuit of Nunavik, Am. J. Clin. Nutr. 76, 85–92.PubMedGoogle Scholar
  15. 15.
    Dewailly, E., Blanchet, C., Gingras, S., Lemieux, S., and Holub, B.J. (2002) Cardiovascular Disease Risk Factors and n−3 Fatty Acid Status in the Adult Population of James Bay Cree, Am. J. Clin. Nutr. 76, 85–92.PubMedGoogle Scholar
  16. 16.
    Dewailly, E.E., Blanchet, C., Gingras, S., Lemieux, S., Sauve, L., Bergeron, J., and Holub, B.J. (2001) Relations Between n−3 Fatty Acid Status and Cardiovascular Disease Risk Factors Among Quebecers, Am. J. Clin. Nutr. 74, 603–611.Google Scholar
  17. 17.
    Simon, J.A., Hodgkins, M.L., Browner, W.S., Neuhaus, J.M., Bernert, J.T., and Hulley, S.B. (1995) Serum Fatty Acids and the Risk of Coronary Heart Disease, Am. J. Epidemiol. 142, 469–476.PubMedGoogle Scholar

Copyright information

© AOCS Press 2003

Authors and Affiliations

  1. 1.College Park

Personalised recommendations